Today: November 30, 2015, 7:16 am

Kris Iyer of Spring Bank to speak at Nucleic Acid R & D Meeting, June 19&20, 2014, San Diego, CA.

Kris Iyer, Chief Scientific Officer at Spring Bank Pharmaceuticals, to give a presentation titled “Small Molecule Nucleic Acid Hybrids – A Novel Platform for Small Molecule Drug Discovery” at the Inaugural Nucleic Acid Research and Development Conference, June 29 & 20, 2014 in San Diego, CA. 2014-04-02 05:23:51
Radhakrishnan Iyer, (Kris) Ph.D. FRSC., is a widely recognized innovator in the fields of nucleic acid chemistry, bioorganic chemistry and pharmaceutical sciences. He has been the Principal Investigator for multiple NIH grants for the development of drugs against Hepatitis viruses. Previously, Kris was the co-founder and VP of Discovery of Origenix Technologies, Inc., where he directed a team of 30 scientists in chemistry and biology and was instrumental in advancing several programs from discovery to clinical development. He was an Associate Director of the Discovery program and Technology Development at Hybridon, Inc.

Previously, Kris was a Professor of Medicinal Chemistry at the University of Bombay, and held Visiting Scientist positions at the University of Texas, M. D. Anderson Cancer Center and at the CBER at FDA/NIH. He received his B.Sc. (Hons) in chemistry, B.Sc. (Tech.), and M.Sc. (Tech.) degrees in Pharmaceuticals and Fine Chemicals from the University of Bombay and Ph.D. in Pharmaceutical Sciences from the University of the Pacific, Stockton, California. Kris carried out postdoctoral work at the Oak Ridge National Laboratory and at the Johns Hopkins University. He has authored over 100 scientific papers, books on organic synthesis and is an inventor of more than 100 filed and issued patents.

For more information, please visit

Press Information
635 W. Foothill Blvd. Monrovia, CA 91016

Kristen Starkey


Published by
Rania hafez

# 256 Words
Related Articles
More From Science
BOC Sciences Introduced Impurities Identification Along [..]
This month, BOC Sciences announced its introduction of impurities identification BOC Sciences manufactures thousands impurities for [..]
Total Solar Eclipse to Hit North America
Residents from about Portland, Oregon, to coastal South Carolina will be able to see the total eclipse on August 21 [..]
Creative Bioarray's New cDNA Sample Enables Deeper [..]
Creative Bioarray, a global leader in the manufacturing of research-use cells including primary cells, tumor cells, stem cells [..]
Creative Diagnostics’ New Policy---Accelerates the Update [..]
Nov 5, NY, USA For gaining global market share, Creative Diagnostics announces the new policy----accelerates the update rate [..]
BOC Sciences Announced Its Optimization of Isotope [..]
BOC Sciences announced its recent optimization of the isotope labeling ( There are in total 12 categories of isotopes provided [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.